Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer

Ryo Sugiura,Masaki Kuwatani,Kazumichi Kawakubo,Kazuma Kishi,Hiroki Yonemura,Shunichiro Nozawa,Masatsugu Ohara,Takehiro Noji,Satoshi Hirano,Naoya Sakamoto
DOI: https://doi.org/10.1002/jhbp.12006
2024-06-08
Journal of Hepato-Biliary-Pancreatic Sciences
Abstract:Background Endoscopic retrograde cholangiography (ERC)‐related procedures, usually performed before biliary tract cancer (BTC) surgery, are associated with increased risk for various complications, which can cause sarcopenia. No study has previously elucidated the relationship between preoperative ERC‐related procedures and sarcopenia/skeletal muscle mass loss. Methods Patients with BTC who underwent radical surgical resection following ERC‐related procedures were included. Skeletal muscle mass was evaluated using the psoas muscle mass index (PMI), which was determined using computed tomography images, and the change in PMI before the initial pre‐ERC and surgery (ΔPMI) was calculated. Risk factors for advanced skeletal muscle mass loss, defined as a large ΔPMI, were evaluated. Results The study cohort included 90 patients with a median age of 72 (interquartile range, 65–75) years. The median PMI pre‐ERC and surgery was 4.40 and 4.15 cm2/m2, respectively (p
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?